These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
86 related items for PubMed ID: 8588929
1. Transcriptional up-regulation of the mouse gene for the muscle-specific subunit of enolase during terminal differentiation of myogenic cells. Lamandé N, Brosset S, Lucas M, Keller A, Rouzeau JD, Johnson TR, Gros F, Ilan J, Lazar M. Mol Reprod Dev; 1995 Jul; 41(3):306-13. PubMed ID: 8588929 [Abstract] [Full Text] [Related]
2. Developmental regulation of Mac25/insulin-like growth factor-binding protein-7 expression in skeletal myogenesis. Damon SE, Haugk KL, Swisshelm K, Quinn LS. Exp Cell Res; 1997 Nov 25; 237(1):192-5. PubMed ID: 9417882 [Abstract] [Full Text] [Related]
3. Myoblast alpha v beta3 integrin levels are controlled by transcriptional regulation of expression of the beta3 subunit and down-regulation of beta3 subunit expression is required for skeletal muscle cell differentiation. Blaschuk KL, Guérin C, Holland PC. Dev Biol; 1997 Apr 15; 184(2):266-77. PubMed ID: 9133434 [Abstract] [Full Text] [Related]
4. Coexpression of alpha and gamma enolase genes in neurons of adult rat brain. Keller A, Bérod A, Dussaillant M, Lamandé N, Gros F, Lucas M. J Neurosci Res; 1994 Aug 01; 38(5):493-504. PubMed ID: 7815469 [Abstract] [Full Text] [Related]
5. Rabbit slow and fast skeletal muscle-derived satellite myoblast phenotypes do not involve constitutive differences in the components of the insulin-like growth factor system. Barjot C, Navarro M, Cotten ML, Garandel V, Bernardi H, Bacou F, Barenton B. J Cell Physiol; 1996 Nov 01; 169(2):227-34. PubMed ID: 8908189 [Abstract] [Full Text] [Related]
6. Transforming growth factor-beta1 upregulates myostatin expression in mouse C2C12 myoblasts. Budasz-Rwiderska M, Jank M, Motyl T. J Physiol Pharmacol; 2005 Jun 01; 56 Suppl 3():195-214. PubMed ID: 16077203 [Abstract] [Full Text] [Related]
7. Osteogenic protein-1 regulates insulin-like growth factor-I (IGF-I), IGF-II, and IGF-binding protein-5 (IGFBP-5) gene expression in fetal rat calvaria cells by different mechanisms. Yeh LC, Adamo ML, Duan C, Lee JC. J Cell Physiol; 1998 Apr 01; 175(1):78-88. PubMed ID: 9491783 [Abstract] [Full Text] [Related]
9. V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: involvement of HIF-1 in tumor progression. Jiang BH, Agani F, Passaniti A, Semenza GL. Cancer Res; 1997 Dec 01; 57(23):5328-35. PubMed ID: 9393757 [Abstract] [Full Text] [Related]
10. Stable expression of antisense Rb-1 RNA inhibits terminal differentiation of mouse myoblast C2 cells. Kobayashi M, Yamauchi Y, Tanaka A. Exp Cell Res; 1998 Feb 25; 239(1):40-9. PubMed ID: 9511723 [Abstract] [Full Text] [Related]
11. Regulation of mda-7 gene expression during human melanoma differentiation. Madireddi MT, Dent P, Fisher PB. Oncogene; 2000 Mar 02; 19(10):1362-8. PubMed ID: 10713678 [Abstract] [Full Text] [Related]
12. The muscle-specific enolase is an early marker of human myogenesis. Fougerousse F, Edom-Vovard F, Merkulova T, Ott MO, Durand M, Butler-Browne G, Keller A. J Muscle Res Cell Motil; 2001 Mar 02; 22(6):535-44. PubMed ID: 12038587 [Abstract] [Full Text] [Related]
13. Myoblast and myotube nuclei display similar patterns of heterogeneous acetylcholine receptor subunit mRNA expression. Su X, Berman SA, Sullivan T, Bursztajn S. J Cell Biochem; 1995 May 02; 58(1):22-38. PubMed ID: 7642720 [Abstract] [Full Text] [Related]
14. Developmental regulation of intermediate filament and actin mRNAs during myogenesis is disrupted by oncogenic ras genes. Olson EN, Capetanaki YG. Oncogene; 1989 Jul 02; 4(7):907-13. PubMed ID: 2666910 [Abstract] [Full Text] [Related]
15. Effects of IGF-I, IGF-II, bFGF and PDGF on the initiation of mRNA translation in C2C12 myoblasts and differentiating myoblasts. Smith CW, Klaasmeyer JG, Woods TL, Jones SJ. Tissue Cell; 1999 Aug 02; 31(4):403-12. PubMed ID: 10522389 [Abstract] [Full Text] [Related]
16. Transcriptional activation of the insulin-like growth factor-II gene during myoblast differentiation. Kou K, Rotwein P. Mol Endocrinol; 1993 Feb 02; 7(2):291-302. PubMed ID: 8469241 [Abstract] [Full Text] [Related]
17. Tumor necrosis factor-alpha and basic fibroblast growth factor differentially inhibit the insulin-like growth factor-I induced expression of myogenin in C2C12 myoblasts. Layne MD, Farmer SR. Exp Cell Res; 1999 May 25; 249(1):177-87. PubMed ID: 10328964 [Abstract] [Full Text] [Related]
18. Dual promoter structure of ZFP106: regulation by myogenin and nuclear respiratory factor-1. Grasberger H, Ye H, Mashima H, Bell GI. Gene; 2005 Jan 03; 344():143-59. PubMed ID: 15656981 [Abstract] [Full Text] [Related]
19. Retrovirally mediated overexpression of insulin-like growth factor binding protein 4: evidence that insulin-like growth factor is required for skeletal muscle differentiation. Damon SE, Haugk KL, Birnbaum RS, Quinn LS. J Cell Physiol; 1998 Apr 03; 175(1):109-20. PubMed ID: 9491786 [Abstract] [Full Text] [Related]
20. Muscle-specific transcription factors in fibroblasts expressing the alpha-striated tropomyosin 3' untranslated region. L'ecuyer TJ, Schutte BC, Mendel KA, Morris E, Fulton AB. Mol Genet Metab; 1999 Jul 03; 67(3):213-26. PubMed ID: 10381329 [Abstract] [Full Text] [Related] Page: [Next] [New Search]